Article: Prostate Cancer Patient in Montpellier Becomes First Cancer Patient in France Treated with Varian's RapidArc(TM) Radiotherapy.

A 60-year-old prostate cancer patient from Montpellier has become the first person in France to be treated using RapidArc(TM) technology from Varian Medical Systems (NYSE:VAR) for fast and precise forms of intensity modulated radiotherapy (IMRT). Each of his treatments at the CRLC Val D'Aurelle - Paul Lamarque in the city took just 75 seconds, several times faster than conventional IMRT treatments. Dr. Pascal Fenoglietto, the hospital's chief medical physicist for scientific projects, presented the case to colleagues at the annual meeting of the French Society of Radiation Oncologists (SFRO) in Paris from November 12- 14 (see also Prostate Cancer).

"The ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!